Literature DB >> 25982218

Exosomes Secreted from Human Cancer Cell Lines Contain Inhibitors of Apoptosis (IAP).

Malyn May Asuncion Valenzuela1, Heather R Ferguson Bennit, Amber Gonda, Carlos J Diaz Osterman, Abby Hibma, Salma Khan, Nathan R Wall.   

Abstract

Exosomes are endosomal-derived nanovesicles released by normal and tumor cells which have been shown to transfer functionally active protein, lipids, mRNAs and miRNAs between cells. Varying in molecular profiles, biological roles, functional roles and protein contents, exosomes have been described as "multi-purpose carriers" playing a role in supporting the survival and growth of tumor cells. The IAP Survivin has been found to be present in tumor exosomes. However, the existence of other IAPs in tumor exosomes is still unknown. Survivin, cIAP1, cIAP2 and XIAP mRNA and protein are differently expressed in a panel of tumor cell lines: DLCL2, HeLa, MCF-7, Panc-1, and PC3. Exosomes were isolated from conditioned media collected from the cells from which RNA and protein were extracted. Our results provide evidence that like Survivin, XIAP, cIAP1 and cIAP2 proteins are found in tumor exosomes. The mRNA expression, however, is differentially expressed across the tumor cell lines. The presence of these bioactive molecules in exosomes may not only serve as warning signals, but also play a role in providing protection to the cancer cells against changes that are constantly occurring in the tumor microenvironment.

Entities:  

Year:  2015        PMID: 25982218      PMCID: PMC4542824          DOI: 10.1007/s12307-015-0167-9

Source DB:  PubMed          Journal:  Cancer Microenviron        ISSN: 1875-2284


  45 in total

1.  Expulsion of small molecules in vesicles shed by cancer cells: association with gene expression and chemosensitivity profiles.

Authors:  Kerby Shedden; Xue Tao Xie; Parthapratim Chandaroy; Young Tae Chang; Gustavo R Rosania
Journal:  Cancer Res       Date:  2003-08-01       Impact factor: 12.701

Review 2.  Exosomes: proteomic insights and diagnostic potential.

Authors:  Richard J Simpson; Justin We Lim; Robert L Moritz; Suresh Mathivanan
Journal:  Expert Rev Proteomics       Date:  2009-06       Impact factor: 3.940

Review 3.  Survivin study: what is the next wave?

Authors:  Fengzhi Li
Journal:  J Cell Physiol       Date:  2003-10       Impact factor: 6.384

4.  Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes.

Authors:  L Zitvogel; A Regnault; A Lozier; J Wolfers; C Flament; D Tenza; P Ricciardi-Castagnoli; G Raposo; S Amigorena
Journal:  Nat Med       Date:  1998-05       Impact factor: 53.440

5.  The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases.

Authors:  N Roy; Q L Deveraux; R Takahashi; G S Salvesen; J C Reed
Journal:  EMBO J       Date:  1997-12-01       Impact factor: 11.598

6.  Survivin is released from cancer cells via exosomes.

Authors:  Salma Khan; Jessica M S Jutzy; Jonathan R Aspe; Dalmor W McGregor; Jonathan W Neidigh; Nathan R Wall
Journal:  Apoptosis       Date:  2011-01       Impact factor: 4.677

7.  Senescence-associated exosome release from human prostate cancer cells.

Authors:  Brian D Lehmann; Matthew S Paine; Adam M Brooks; James A McCubrey; Randall H Renegar; Rong Wang; David M Terrian
Journal:  Cancer Res       Date:  2008-10-01       Impact factor: 12.701

Review 8.  Survivin, cancer networks and pathway-directed drug discovery.

Authors:  Dario C Altieri
Journal:  Nat Rev Cancer       Date:  2008-01       Impact factor: 60.716

9.  The amount and proteolytic content of vesicles shed by human cancer cell lines correlates with their in vitro invasiveness.

Authors:  A Ginestra; M D La Placa; F Saladino; D Cassarà; H Nagase; M L Vittorelli
Journal:  Anticancer Res       Date:  1998 Sep-Oct       Impact factor: 2.480

Review 10.  Exosome: from internal vesicle of the multivesicular body to intercellular signaling device.

Authors:  K Denzer; M J Kleijmeer; H F Heijnen; W Stoorvogel; H J Geuze
Journal:  J Cell Sci       Date:  2000-10       Impact factor: 5.285

View more
  22 in total

1.  Emerging roles of tetraspanins in plant inter-cellular and inter-kingdom communication.

Authors:  Saul Jimenez-Jimenez; Kenji Hashimoto; Olivia Santana; Jesús Aguirre; Kazuyuki Kuchitsu; Luis Cárdenas
Journal:  Plant Signal Behav       Date:  2019-03-04

Review 2.  Pathogenic role of exosomes and microRNAs in HPV-mediated inflammation and cervical cancer: A review.

Authors:  Javid Sadri Nahand; Mohsen Moghoofei; Arash Salmaninejad; Zahra Bahmanpour; Mohammad Karimzadeh; Mitra Nasiri; Hamid Reza Mirzaei; Mohammad Hossein Pourhanifeh; Farah Bokharaei-Salim; Hamed Mirzaei; Michael R Hamblin
Journal:  Int J Cancer       Date:  2019-10-31       Impact factor: 7.396

Review 3.  The multifaceted role of exosomes in cancer progression: diagnostic and therapeutic implications [corrected].

Authors:  Vignesh Sundararajan; Fazlul H Sarkar; Thamil Selvee Ramasamy
Journal:  Cell Oncol (Dordr)       Date:  2018-04-17       Impact factor: 6.730

4.  Proteomic Profiling of Serum-Derived Exosomes from Ethnically Diverse Prostate Cancer Patients.

Authors:  David Turay; Salma Khan; Carlos J Diaz Osterman; Matthew P Curtis; Balreet Khaira; Jonathan W Neidigh; Saied Mirshahidi; Carlos A Casiano; Nathan R Wall
Journal:  Cancer Invest       Date:  2015-11-04       Impact factor: 2.176

Review 5.  Emerging therapies provide new opportunities to reshape the multifaceted interactions between the immune system and lymphoma cells.

Authors:  M Pizzi; M Boi; F Bertoni; G Inghirami
Journal:  Leukemia       Date:  2016-06-08       Impact factor: 11.528

6.  Exosomes: Potential in Cancer Diagnosis and Therapy.

Authors:  Phillip Munson; Arti Shukla
Journal:  Medicines (Basel)       Date:  2015-11-02

Review 7.  Exosomes and Other Extracellular Vesicles in HPV Transmission and Carcinogenesis.

Authors:  David Guenat; François Hermetet; Jean-Luc Prétet; Christiane Mougin
Journal:  Viruses       Date:  2017-08-07       Impact factor: 5.048

8.  Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.

Authors:  Stephanie N Hurwitz; Mark A Rider; Joseph L Bundy; Xia Liu; Rakesh K Singh; David G Meckes
Journal:  Oncotarget       Date:  2016-12-27

Review 9.  Survivin: a unique target for tumor therapy.

Authors:  Himani Garg; Prerna Suri; Jagdish C Gupta; G P Talwar; Shweta Dubey
Journal:  Cancer Cell Int       Date:  2016-06-23       Impact factor: 5.722

Review 10.  Tumor-derived exosomes in cancer progression and treatment failure.

Authors:  Shaorong Yu; Haixia Cao; Bo Shen; Jifeng Feng
Journal:  Oncotarget       Date:  2015-11-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.